Valganciclovir N-Valyl Impurity

Valganciclovir N-Valyl Impurity is a structurally related degradation byproduct arising from the amidation of the parent drug's ganciclovir core with an N-valyl moiety. It retains the acyclic nucleoside scaffold of valganciclovir but features an altered side chain configuration due to incomplete coupling during synthetic steps. The compound contains a 2-amino-1,6-dihydro-6-oxo-pyrimidin-9-yl group linked to a valine-derived amino acid via an amide bond, with a terminal acetyl group. This impurity is critical for validating analytical methods in quality control, serving as an HPLC reference standard to quantify process-related impurities in valganciclovir formulations.